Lipid Nanoparticles as Carriers for RNAi against Viral Infections: Current Status and Future Perspectives

The efforts made to develop RNAi-based therapies have led to productive research in the field of infections in humans, such as hepatitis C virus (HCV), hepatitis B virus (HBV), human immunodeficiency virus (HIV), human cytomegalovirus (HCMV), herpetic keratitis, human papillomavirus, or influenza virus. Naked RNAi molecules are rapidly digested by nucleases in the serum, and due to their negative surface charge, entry into the cell cytoplasm is also hampered, which makes necessary the use of delivery systems to exploit the full potential of RNAi therapeutics. Lipid nanoparticles (LNP) represent one of the most widely used delivery systems for in vivo application of RNAi due to their relative safety and simplicity of production, joint with the enhanced payload and protection of encapsulated RNAs. Moreover, LNP may be functionalized to reach target cells, and they may be used to combine RNAi molecules with conventional drug substances to reduce resistance or improve efficiency. This review features the current application of LNP in RNAi mediated therapy against viral infections and aims to explore possible future lines of action in this field.

Sentence comprehension before and after 1970: Topics, debates and techniques

[EN] Language Down the Garden Path traces the lines of research that grew out of Bever's classic paper. Leading scientists review over 40 years of debates on the factors at play in language comprehension, production, and acquisition (the role of prediction, grammar, working memory, prosody, abstractness, syntax and semantics mapping); the current status of universals and narrow syntax; and virtually every topic relevant in psycholinguistics since 1970. Written in an accessible and engaging style, the book will appeal to all those interested in understanding the questions that shaped, and are still shaping, this field and the ways in which linguists, cognitive scientists, psychologists, and neuroscientists are seeking to answer them.

¿Reemplazo demográfico en el Neolítico europeo? El punto de vista de la Genética

[ES] El trabajo realiza una aproximación a la situación actual de los estudios de ADN antiguo humano en Europa, recopilando los datos de los individuos analizados hasta 2013 (n=700), a modo de síntesis interpretativa continental y regional de los territorios para los cuales se han obtenido resultados significativos (Centroeuropa, Cornisa Cantábrica, Mediterráneo occidental, Escandinavia-Báltico-Rusia y Alpes orientales). Las hipótesis se expresan en términos de continuidad o discontinuidad genética entre los grupos humanos habitantes de un territorio, centradas en la problemática de la neolitización, en una horquilla cronocultural del Paleolítico superior a la Edad del Bronce. Los resultados se resumen en (1) una preponderancia del clado mitocondrial U para muestras preneolíticas; (2) la posibilidad de una intrusión démica en una fase inicial de la neolitización centroeuropea -tipo N1a, con pérdida posterior de ese haplogrupo mitocondrial-; (3) la evidencia del proceso neolitizador como heterogéneo y con diferente impacto a escala regional; (4) una estabilización del acervo genético europeo actual como resultado de eventos postneolíticos; y (5) las posibilidades analíticas de la genética aplicada a las poblaciones antiguas como un instrumento de gran interés, observándose la necesidad de realizar más analíticas con recorrido diacrónico.

Ética y sostenibilidad en los trabajos fin de grado.

[ES]El objetivo de este TFG es estudiar la situación actual de los conceptos ética y sostenibilidad dentro de la disciplina de la dirección de proyectos e investigar cuál es el papel de estos valores dentro del plan de estudios de la ETSI (Escuela Técnica Superior de Ingeniería) de Bilbao. Para ello el trabajo de documentación se complementará con entrevistas realizadas a gente relevante del centro que ayudarán con su visión y experiencia sobre el tema. Tras recopilar esta información se presentará una propuesta de cambio en el método de evaluación para considerar estos aspectos en los trabajos finales de los alumnos de esta escuela.

Current Approaches for Predicting a Lack of Response to Anti-EGFR Therapy in KRAS Wild-Type Patients

Targeting epidermal growth factor receptor (EGFR) has been one of the most effective colorectal cancer strategies. Anti-EGFR antibodies function by binding to the extracellular domain of EGFR, preventing its activation, and ultimately providing clinical benefit. KRAS mutations in codons 12 and 13 are recognized prognostic and predictive biomarkers that should be analyzed at the clinic prior to the administration of anti-EGFR therapy. However, still an important fraction of KRAS wild-type patients do not respond to the treatment. The identification of additional genetic determinants of primary or secondary resistance to EGFR targeted therapy for further improving the selection of patients is urgent. Herein, we review the latest published literature highlighting the most important genes that may predict resistance to anti-EGFR monoclonal antibodies in colorectal cancer patients. According to the available findings, the evaluation of BRAF, NRAS, PIK3CA, and PTEN status could be the right strategy to select patients who are likely to respond to anti-EGFR therapies. In the future, the combination of those biomarkers will help establish consensus that can be introduced into clinical practice.